Assyro AI

FDA Orange Book · active-ingredient family

Pancuronium bromide

Pancuronium bromide is approved as 1 brand and 11 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:PAVULON · NDA 017015

1

Brand (NDA)

11

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
PAVULONRLD×2ORGANON USA INCNDA 017015Approved Prior to Jan 1, 1982

Generic (ANDA) products (11)

ProductApplicantApplicationTEApproved
PANCURONIUM BROMIDEDR REDDYSANDA 072759Jul 31, 1990
PANCURONIUM BROMIDEDR REDDYSANDA 072760Jul 31, 1990
PANCURONIUM BROMIDEHOSPIRAANDA 072320Jan 19, 1989
PANCURONIUM BROMIDEHOSPIRAANDA 072321Jan 19, 1989
PANCURONIUM BROMIDEIGI LABS INCANDA 072210Mar 31, 1988
PANCURONIUM BROMIDEIGI LABS INCANDA 072211Mar 31, 1988
PANCURONIUM BROMIDEIGI LABS INCANDA 072212Mar 31, 1988
PANCURONIUM BROMIDEIGI LABS INCANDA 072213Mar 31, 1988
PANCURONIUM BROMIDEELKINS SINNANDA 072058Mar 23, 1988
PANCURONIUM BROMIDEELKINS SINNANDA 072059Mar 23, 1988
PANCURONIUM BROMIDEELKINS SINNANDA 072060Mar 23, 1988

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Pancuronium bromide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.